CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 



Caladrius Biosciences, Inc.  (NBS)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 
 

Caladrius Biosciences Growth Comparisons

Select each growth Category to receive further Information

Select the Comparisons : Select the Ratio:                        

NBS Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q1 MRQ) 5.78 % -2.64 % 5.12 % 6.92 %
Q / Q Revenue Growth (Q1 MRQ) -22.15 % -4.33 % 1.46 % -4.34 %
Y / Y Revenue Growth (for 12 months ending Q1 TTM) 33.25 % 0.23 % 3.25 % %
Seq. Revenue Growth (for 12 months ending Q1 TTM) 1.23 % -1.39 % 0.85 % 2.84 %
Revenue 5 Year Average Growth -13.7 % 7.08 % 9.77 % 14.11 %
Expected Revenue Growth (Y/Y) - - 1.89 % 2.7 %


NBS's Growth Comparisons in I. Quarter 2017


You need to upgrade your Flash Player


Caladrius Biosciences managed to grow Revenue by 5.78% year on year, in the first quarter 2017 to 8 millions, while Biotechnology & Drugs industry fell by -2.64%, Healthcare sector grew 5.12%. Slow first quarter sales, in Biotechnology & Drugs industry and Healthcare sector, were portrayed in Caladrius Biosciences, Inc. results which underperformed overall market.

Comparing company's Revenue to the forth quarter results, sales were lower by -22.15% . On the annual basis, average annual sales growth for Caladrius Biosciences is -13.7%, while S & P 500's including only Businesses with the first quarter 2017 2017 Results, average yearly sales growth is 14.11% over the past five years.


Growth Rates of NBS's Income in the first quarter 2017


NBS Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q1 MRQ) - -13.4 % 0.95 % 34.97 %
Seq. Operating Income Change (Q1 MRQ) - 14.17 % 39.96 % 7.52 %
Y / Y Operating Income Growth (Q1 TTM) - -13.25 % 7.69 % 30.01 %
Seq. Operating Income Growth (Q1 TTM) - -5.47 % -1.39 % 24.98 %
Operating Income 5 Year Avg. Change - 14.95 % -0.85 % 13.22 %

Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q1 MRQ) - -15.32 % -1.49 % 25.02 %
Seq. Income from Cont. Ops. Change (Q1 MRQ) - 26.25 % 124.87 % 21.95 %
Y / Y Income from Cont. Ops. Change (Q1 TTM) - -20.47 % -10.76 % 9.56 %
Seq. Income from Cont. Ops. Change (Q1 TTM) - -7.02 % -4.2 % 6.25 %
Income from Cont. Ops. 5 Year Avg. Change - 12.88 % 1.31 % 15.43 %

NBS Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q1 MRQ) - -15.42 % -2.07 % 19.86 %
Q / Q Net Income Growth (Q1 MRQ) - 24.81 % 104.43 % 17.01 %
Y / Y Net Income Change (Q1 TTM) - -20.53 % -7.76 % 10.3 %
Seq. Net Income Change (Q1 TTM) - -7.01 % -4.62 % 5.32 %
Net Income 5 Year Avg. Growth - 24.55 % 4.53 % 15.42 %

NBS's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q1 MRQ) - -90.55 % -1.49 % 25.02 %
Seq. EPS from Cont. Ops. Change (Q1 MRQ) - -82.39 % 124.87 % 21.95 %
Y / Y EPS from Cont. Ops. Change (Q1 TTM) - - - -
Seq. EPS from Cont. Ops. Change (Q1 TTM) - - - 7.2 %
EPS from Cont. Ops. 5 Year Avg. Growth - NAN % 1.31 % 15.43 %

You need to upgrade your Flash Player

NBS EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q1 MRQ) - -90.56 % -2.07 % 15.43 %
Q / Q EPS Net Growth (Q1 MRQ) - -82.59 % 104.43 % 17.01 %
Y / Y EPS Net Change (for 12 months ending Q1 TTM) - - - 22.56 %
Seq. EPS Net Change (for 12 months ending Q1 TTM) - - - 7.53 %
EPS Net 5 Year Avg. Change - 24.55 % 4.53 % 15.42 %
Expected EPS Growth (Y/Y) - - 123.59 % 27.58 %



Caladrius Biosciences reported bottom-line of $ -1.12 in the first quarter, compare to $ -0.21 in the same quarter a year ago. Biotechnology & Drugs industry fell by -90.56%, while Healthcare sector decreased by -2.07%, and overall market improved by 19.86%.

Comparing company's EPS to the forth quarter results, income per share were lower by -22.15% . On the annual basis, average annual income per share growth for Caladrius Biosciences is -13.7%, while S & P 500's including only Businesses with the first quarter 2017 financial reports, average yearly income per share growth is 15.42% over the past five years.

NBS Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q1 MRQ) - -18.27 % 13.8 % 2.02 %
Seq. Free Cash Flow Change (Q1 MRQ) - -36.45 % -38.97 % -51.53 %
Y / Y Free Cash Flow Change (Q1 TTM) - -0.47 % 8.16 % -2 %
Seq. Free Cash Flow Change (Q1 TTM) - -5.39 % -1.37 % -1.39 %
Free Cash Flow 5 Year Avg. Change - 11.55 % 5.19 % 15.98 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q1 MRQ) - - - 18.81 %
Seq. Net Cash Flow Change (Q1 MRQ) - 169.49 % - -
Y / Y Net Cash Flow Change (Q1 TTM) - - 36.94 % -74.97 %
Seq. Net Cash Flow Change (Q1 TTM) - - 18.52 % -46.5 %
Net Cash Flow 5 Year Avg. Change - - -17.46 % 25.68 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q1 MRQ) -83.61 % 237.87 % 17.94 % -3.99 %
Seq. Capital Expenditures Change (Q1 MRQ) -67.9 % -60.24 % -37.49 % -37.96 %
Y / Y Capital Expenditures Change (Q1 TTM) - 61.39 % 11.24 % -1.72 %
Seq. Capital Expenditures Change (Q1 TTM) -30.66 % 20.13 % 2.58 % -1.85 %
Capital Expenditures 5 Year Avg. Change - - - -

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 
Economy

Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Productivity
Employment Situation
US International Trade
Factory Orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales
Stocks

Event Calendar
GHDC's Profile
Stock Price
GHDC's Financials
GHDC's Expectations
Business Description
Fundamentals
Charts & Quotes
GHDC's News
Suppliers
GHDC's Competitors
Customers & Markets
Economic Indicators
GHDC's Growth
Company Segments
Industries

At a Glance
Performance
Growth Rates
Profitability
Valuation
Financial Strength
Markets

At a Glance
Stocks
Indices
Sectors & Industries
Financials
Commodities
Currencies
Screening

Stock Performance
Growth Rates
Profitability
Valuation
Dividend
Financial Strength
Efficiency
Expectations
Management Effectivness
News

At a Glance
Stocks
Economy
Industries
Other
Glossary

Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms
Help

Sitemap
Advertise
About us
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com